Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Medecine Sciences : M/S|February 1, 2012
[Toll-like receptor 8: the awkward TLR]Lena Alexopoulou, Benoit Desnues, Olivier DemariaThe Journal of Investigative Dermatology|June 14, 2014
Plasmacytoid dendritic cells in melanoma: can we revert bad into good?Jeremy Di Domizio, Olivier Demaria, Michel GillietSeminars in Immunopathology|September 17, 2014
Immune sensing of nucleic acids in inflammatory skin diseasesOlivier Demaria, Jeremy Di Domizio, Michel GillietEuropean Journal of Immunology|June 19, 2021
Natural killer cell engagers in cancer immunotherapy: Next generation of immuno-oncology treatmentsOlivier Demaria, Laurent Gauthier, Guilhaume Debroas, et al.Nature Reviews. Immunology|January 25, 2024
New immune cell engagers for cancer immunotherapyAurore Fenis, Olivier Demaria, Laurent Gauthier, et al.Autoimmunity|March 2, 2010
Contribution of TLR7 and TLR9 signaling to the susceptibility of MyD88-deficient mice to myocarditisPhilippe P Pagni, Stephanie Traub, Olivier Demaria, et al.Nature|October 4, 2019
Harnessing innate immunity in cancer therapyOlivier Demaria, Stéphanie Cornen, Marc Daëron, et al.Nature|November 21, 2019
Publisher Correction: Harnessing innate immunity in cancer therapyOlivier Demaria, Stéphanie Cornen, Marc Daëron, et al.Plos One|October 3, 2012
Sex bias in susceptibility to MCMV infection: implication of TLR9Stephanie Traub, Olivier Demaria, Lionel Chasson, et al.Pageof 4